News
India's one-shot dengue vaccine 'DengiAll' reaches 70% enrolment in Phase III trials across 20 national sites.
Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback